Freenome, Siemens Join Forces to Develop Blood Test for Breast Cancer
The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening, Fierce Biotech reports.
The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening, Fierce Biotech reports.
The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.